Clinica Baviera (XMAD:CBAV) ROE % Adjusted to Book Value: 8.12% (As of Mar. 2026)


XMAD:CBAV Clinica Baviera SA XMAD:CBAV
99 GF Score
Price €55.20
GF Value €41.30
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Clinica Baviera ROE % Adjusted to Book Value?

Clinica Baviera XMAD:CBAV -0.36% 99 ROE % Adjusted to Book Value is 8.12% as of Mar. 2026. GuruFocus rates XMAD:CBAV with a GF Score™ of 99/100 and a GF Value™ of €41.30 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Clinica Baviera's ROE % for the quarter that ended in Mar. 2026 was 50.21%. Clinica Baviera's PB Ratio for the quarter that ended in Mar. 2026 was 6.18. Clinica Baviera's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 8.12%.

Clinica Baviera ROE % Adjusted to Book Value Related Terms

Clinica Baviera ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Clinica Baviera's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera ROE % Adjusted to Book Value Chart

Clinica Baviera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.73 11.42 11.03 8.31 5.62

Clinica Baviera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.65 5.16 3.66 7.37 8.12

XMAD:CBAV vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Clinica Baviera's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinica Baviera ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's ROE % Adjusted to Book Value falls into.


XMAD:CBAV
99GF Score
Clinica Baviera SA XMAD:CBAV
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinica Baviera ROE % Adjusted to Book Value Calculation

Clinica Baviera's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=40.66% / 7.24
=5.62%

Clinica Baviera's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=50.21% / 6.18
=8.12%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 8.12% mean?
Clinica Baviera (XMAD:CBAV) has a ROE % Adjusted to Book Value of 8.12% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Clinica Baviera and its competitors.
Is Clinica Baviera's ROE % Adjusted to Book Value too high?
Clinica Baviera's current ROE % Adjusted to Book Value is 8.12%. Overall, Clinica Baviera has a GF Score™ of 99/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's ROE % Adjusted to Book Value compare to TMO and DHR?
Clinica Baviera's ROE % Adjusted to Book Value of 8.12% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current ROE % Adjusted to Book Value is 8.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.30, compared to a current price of €55.20 — trading 33.7% above its estimated fair value. The current ROE % Adjusted to Book Value is 8.12%. Clinica Baviera's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current ROE % Adjusted to Book Value is 8.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €55.20 is trading 33.7% above its estimated GF Value™ of €41.30. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • ROE % Adjusted to Book Value: 8.12%
  • GF Value™: €41.30 vs. price of €55.20 (33.7% above fair value)
  • GF Score™: 99/100 with 4 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
99GF Score

Get the complete analysis for XMAD:CBAV

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.20
Price
€41.30
GF Value